FDA scientists opposed Trump administration’s move to ease peptide access
A strategy to provide individuals in the United States simpler access to unverified peptide drugs preferred by the United States health secretary, Robert F Kennedy Jr, was opposed by a lot of Food and Drug Administration clinical employee, who had actually restricted input in preparing the policy, according to 6 individuals acquainted with its advancement. … Read more